Study investigator David Berg explains why volume overload shouldn't decide which hospitalized patients get an SGLT2 inhibitor.
|Videos|August 25, 2016
Unintended Consequences of the ACA on Specialty Pharmacy
Author(s)Lauren Santye, Assistant Editor
Marc O'Connor, chief operating officer of Curant Health, discusses how the Affordable Care Act has impacted specialty pharmacy stakeholders.
Advertisement
Marc O'Connor, chief operating officer of Curant Health, discusses how the Affordable Care Act has impacted specialty pharmacy stakeholders.
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Pharmacy Times
1
After 180 Years, Multiple Myeloma Gets a Definition of Cure
2
Psilocybin-Assisted Therapy for AUD: Emerging Evidence, Clinical and Cost Implications, and Treatment Gaps
3
Armored CAR T-Cell Therapy Produces Durable Complete Response in Pediatric Solid Tumors
4
Not So Rare After All: Pharmacists Weigh In on Diagnosing and Managing ATTR-CM
5